Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2020 | Monitoring aggregate-prone proteins in vivo: steps toward a treatment for neurodegenerative diseases

Angeleen Fleming • 28 Apr 2020
ARUK 2020
General

Angeleen Fleming, PhD, University of Cambridge, Cambridge, UK, discusses a recently developed technique for monitoring the clearance of aggregate-prone proteins within neurons in vivo. This technique can be used to assess genetic modifiers of disease, screen for and validate potential therapeutic agents and manipulate the proteasome. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

More from Angeleen Fleming

Tools to monitor autophagy in vivo
3:51
Tools to monitor autophagy in vivo
Angeleen Fleming • 28 Apr 2020
The role of autophagy in neurodegeneration
1:29
The role of autophagy in neurodegeneration
Angeleen Fleming • 28 Apr 2020

Related Videos

The future of AI in neurology
1:12
The future of AI in neurology
Vijaya B. Kolachalama • 8 Apr 2025
AI in neurology: evaluation and clinical implementation
2:08
AI in neurology: evaluation and clinical implementation
Vijaya B. Kolachalama • 8 Apr 2025
Brain-body communication in neurodegenerative diseases
1:04
Brain-body communication in neurodegenerative diseases
Katerina Akassoglou • 18 Jul 2023
Using 7-Tesla MRI to study cerebral impacts of COVID-19 infection
2:36
Using 7-Tesla MRI to study cerebral impacts of COVID-19 infection
Tamer Ibrahim • 24 Jul 2023

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals